Eindhoven, Netherlands - On March 23, 2026, ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), a prominent neurotechnology firm specializing in innovative treatments for enhancing movement abilities in individuals with spinal cord injury and other movement impairments, declared its plan to unveil the Full-Year 2025 Financial Results. The company will also conduct a webcast offering an extensive business overview on March 31, 2026.